Literature DB >> 26156533

Prostate cancer recurrence: can PSA guide imaging?

P Mapelli1, V Panebianco2, Maria Picchio3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26156533     DOI： 10.1007/s00259-015-3091-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  11 in total

1.  [11C]choline positron emission tomography/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen.

Authors:  Giampiero Giovacchini; Maria Picchio; Rita Garcia-Parra; Paola Mapelli; Alberto Briganti; Francesco Montorsi; Luigi Gianolli; Cristina Messa
Journal:  J Urol       Date:  2012-11-16       Impact factor: 7.450

2.  Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.

Authors:  Chung Yao Yu; Bhushan Desai; Lingyun Ji; Susan Groshen; Hossein Jadvar
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

3.  Potential of hybrid ¹⁸F-fluorocholine PET/MRI for prostate cancer imaging.

Authors:  Thomas de Perrot; Olivier Rager; Max Scheffler; Martin Lord; Marc Pusztaszeri; Christophe Iselin; Osman Ratib; Jean-Paul Vallee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-20       Impact factor: 9.236

Review 4.  Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy.

Authors:  Andrew K Lee; Anthony V D'Amico
Journal:  J Clin Oncol       Date:  2005-11-10       Impact factor: 44.544

Review 5.  The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer.

Authors:  Maria Picchio; Alberto Briganti; Stefano Fanti; Axel Heidenreich; Bernd J Krause; Cristina Messa; Francesco Montorsi; Sven N Reske; George N Thalmann
Journal:  Eur Urol       Date:  2010-09-15       Impact factor: 20.096

6.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

Review 7.  EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.

Authors:  Axel Heidenreich; Patrick J Bastian; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Theodor van der Kwast; Malcolm Mason; Vsevolod Matveev; Thomas Wiegel; Filiberto Zattoni; Nicolas Mottet
Journal:  Eur Urol       Date:  2013-11-12       Impact factor: 20.096

8.  Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.

Authors:  Valeria Panebianco; Flavio Barchetti; Alessandro Sciarra; Daniela Musio; Valerio Forte; Vincenzo Gentile; Vincenzo Tombolini; Carlo Catalano
Journal:  Eur Radiol       Date:  2013-02-02       Impact factor: 5.315

9.  Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

Authors:  Ali Afshar-Oromieh; Christian M Zechmann; Anna Malcher; Matthias Eder; Michael Eisenhut; Heinz G Linhart; Tim Holland-Letz; Boris A Hadaschik; Frederik L Giesel; Jürgen Debus; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-27       Impact factor: 9.236

Review 10.  Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.

Authors:  Valeria Panebianco; Flavio Barchetti; Daniela Musio; Francesca De Felice; Camilla Proietti; Elena Lucia Indino; Valentina Megna; Orazio Schillaci; Carlo Catalano; Vincenzo Tombolini
Journal:  Biomed Res Int       Date:  2014-03-13       Impact factor: 3.411
View more
  2 in total

1.  Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy.

Authors:  Lino M Sawicki; Julian Kirchner; Carolin Buddensieck; Christina Antke; Tim Ullrich; Lars Schimmöller; Johannes Boos; Christoph Schleich; Benedikt M Schaarschmidt; Christian Buchbender; Philipp Heusch; Robert Rabenalt; Peter Albers; Gerald Antoch; Hans-Wilhelm Müller; Hubertus Hautzel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-16       Impact factor: 9.236

Review 2.  Target Definition in Salvage Radiotherapy for Recurrent Prostate Cancer: The Role of Advanced Molecular Imaging.

Authors:  Gaël Amzalag; Olivier Rager; Claire Tabouret-Viaud; Michael Wissmeyer; Electra Sfakianaki; Thomas de Perrot; Osman Ratib; Raymond Miralbell; Giampiero Giovacchini; Valentina Garibotto; Thomas Zilli
Journal:  Front Oncol       Date:  2016-03-31       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.